Cargando…
The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the fifth most common malignancy worldwide and the second most lethal human cancer. A portion of patients with advanced HCC can significantly benefit from treatments with sorafenib, adriamycin, 5-fluorouracil and platinum drugs. However, most HCC patients eventually...
Autores principales: | Wei, Ling, Wang, Xingwu, Lv, Liyan, Liu, Jibing, Xing, Huaixin, Song, Yemei, Xie, Mengyu, Lei, Tianshui, Zhang, Nasha, Yang, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6814027/ https://www.ncbi.nlm.nih.gov/pubmed/31651347 http://dx.doi.org/10.1186/s12943-019-1086-z |
Ejemplares similares
-
Noncoding RNAs in gastric cancer: implications for drug resistance
por: Wei, Ling, et al.
Publicado: (2020) -
Noncoding RNAs: an emerging modulator of drug resistance in pancreatic cancer
por: Wei, Ling, et al.
Publicado: (2023) -
Decoding Noncoding RNAs: Role of MicroRNAs and Long Noncoding RNAs in Ocular Neovascularization
por: Zhang, Yan, et al.
Publicado: (2017) -
Potential Regulatory Roles of MicroRNAs and Long Noncoding RNAs in Anticancer Therapies
por: Xie, Mengyan, et al.
Publicado: (2018) -
The Emerging Role of MicroRNAs in Hepatocellular Carcinoma
por: Akkiz, Hikmet
Publicado: (2014)